Read the latest news stories in diabetes tech, research and innovation.
Dexcom
+1
/
Dec 10, 2025
Dexcom is set to end production of the Dexcom G6 on July 1, 2026 and begin shifting users toward its Dexcom G7 platform.
News
+2
Dec 4, 2025
Insulet’s latest 510(k) clearance introduces a lower target and automation tweaks aimed at improving time in range and increasing time in automation.
Future Tech
+3
From brainwave sensors to long-term implants, the next wave of continuous glucose monitors is pushing beyond today’s skin patches.
+4
Dec 3, 2025
The collaboration could aid insulin delivery for people who require higher doses and extend wear time. Trials are expected to begin in 2026.
Medtronic
Dec 2, 2025
Medtronic's latest CGM built by Abbott, the Instinct, brings 15-day wear and a smaller design to MiniMed 780G users in the U.S.
Abbott recalls 3 million Libre 3 CGMs after detecting potential low glucose reading errors, impacting user safety, with 736 reported adverse events and seven deaths.
Nov 25, 2025
The algorithm update brings a reduced glucose target, enhanced algorithm performance, wider CGM choice, and a new insights platform called Discover.
As Medtronic prepares for a planned MiniMed spinoff in 2026, its next-generation Fit and Flex pumps and algorithm updates are making progress.
Nov 24, 2025
The upcoming platform will deliver weekly insights to help pump users and HCPs simplify AID data review for Omnipod 5 and Omnipod DASH.
During Its First Investor Day, Insulet Reveals Omnipod 5 Enhancements, Omnipod 6 Advancements, the New Discover Platform and a Fully Closed Loop Plan for Type 2 Diabetes
Nov 20, 2025
Longer wear, improved accuracy and new features arrive with Dexcom’s latest G7 CGM update.
Nov 19, 2025
The company’s latest feature uses continuous data to guide daily basal dose adjustments for people with type 2 diabetes.
Nov 11, 2025
Tandem Mobi users will be able to control their pump with Android phones later this year.
CGM
Nov 6, 2025
The regulatory milestone positions Eversense 365 for a 2026 European launch and marks a major step forward in long-term glucose monitoring technology.
Nov 4, 2025
The collaboration will link wearable, sleep, and menstrual cycle data with glucose trends to close long-standing gaps in women’s health and diabetes research.
Oct 29, 2025
All U.S. t:slim X2 users have access to FreeStyle Libre 3 Plus CGM integration, with international early-access programs rolling out later this year.
New laws and state-run manufacturing aim to make insulin more affordable to all Californians starting in 2026, setting a national example for diabetes care reform.
Oct 28, 2025
A California parent says Dexcom’s G7 continuous glucose monitor gave false readings and missed life-saving alerts, sparking a class action and renewed concerns over CGM safety.
Oct 15, 2025
The move to end research into a potential type 1 diabetes cure has left many people with diabetes frustrated, reflective, and still holding on to hope.
Oct 14, 2025
The FDA has accepted MannKind’s application to expand the use of its inhaled insulin, Afrezza, to children, marking a key step toward potential pediatric approval.
Oct 7, 2025
Biolinq’s Shine biosensor uses needle-free technology and real-time LED feedback to track glucose for people with type 2 diabetes.
Roche’s latest integration brings AI-driven glucose predictions, personalized logging, and easy data sharing into one connected platform.
Sep 30, 2025
FDA clears Tandem’s t:slim X2 insulin pump for use with Lilly’s ultra-rapid Lyumjev insulin, expanding options beyond Humalog and Novolog.
Sep 25, 2025
We got an early look the upcoming Trends tab coming to Dexcom G7, which brings food, exercise, insulin, and glucose data into one dashboard — rolling out soon in the U.S.
Sep 24, 2025
We got a first look at the FDA-cleared 7-day SteadiSet infusion set coming to all Tandem pumps in the U.S next year.
